Corporate Radar: SKF India, Whirlpool to turn ex-dividend; Tata Steel, Britannia AGMs; stock splits and moreTata Steel, Britannia Industries, Devyani International, Bank of Maharashtra, Sundaram Clayton, Elecon Engineering Company, Bliss GVS Pharm...
Corporate Radar: PNB, Union Bank to turn ex-dividend, SBI AGM; Q4 results, bonus issues & moreWednesday is also the record date for dividends by Britannia Industries, Bank of Maharashtra, Agro Tech Foods, Bliss GVS Pharma, Bharat Sea...
Bliss GVS Pharma shares jump 13% after strong show in June quarterShares of Bliss GVS Pharma have remained an underperformer in the last one year.
NSE-BSE bulk deals: LTS Investment buys stake in Bliss GVS and other dealsShares of Bliss GVS Pharma ended 0.5 per cent higher at Rs 204.65.
- Buy Bliss GVS Pharma, target Rs 214: Kunal Bothra
Buy Bliss GVS Pharma Ltd. at a price target of Rs 214.0 and a stop loss at Rs 192 from entry point.
- Buy Bliss GVS Pharma Ltd, target Rs 220.0 : Kunal Bothra
Buy Bliss GVS Pharma Ltd. at a price target of Rs 220.0 and a stop loss at Rs 180.0 from entry point
Bliss GVS Pharma arm wins $111 million contract from Kenyan firmBliss GVS Pharma stock was trading 2.97 per cent higher at Rs 123.05 per scrip in the afternoon trade on BSE today.
Top five stocks that gained upto 20%While Indian markets fell over 300 points after a resounding 'no' vote, some stocks ignored the crisis and rallied in a sinking market.
Bliss GVS Pharma wins $35 mn contract in KenyaBliss GVS Pharma has won an annual service contract worth $35 million (over Rs 220 crore) in Kenya for providing medical healthcare cover i...
Ghana drug regulator blacklists Indian firmIndian pharmaceutical firm Bliss GVS Pharma has been banned by Ghana's health watchdog from importing and distributing medicinal products t...
Indian pharma company in dock over fake medicines in GhanaIndian drugmakers continue to find themselves on the wrong side of global regulators, with the latest being Maharashtra-based Bliss GVS Pha...
- Tata Communications Q3 net loss at Rs 201 crore
The company had posted a net loss of Rs 153.06 crore in the same period a year ago.
- Bliss GVS Pharma acquires 70 pc stake in Kremoint Pharma
"The company has acquired 70 per cent management stake in the Kremoint Pharma Private Limited," Bliss GVS Pharma said in a filing to BSE.
Spiritual guru Gopal Hari Das found guilty of immigration fraud in the USAccording to evidence at the trial, Haldar conspired to sponsor more than two dozen Indian nationals to enter the US under the R-1 visas.
- Bliss GVS Pharma Q1 Net up 28.81 pc to Rs 13.59 crore
Bliss GVS Pharma on Friday said its net profit rose by 28.81 per cent to Rs 13.59 crore for the first quarter ended June 30, 2011, over the...
- Bliss GVS Pharma Q3 net dips 1.5 pc to Rs 13.60 cr
Bliss GVS Pharma today said its net profit declined by 1.5 per cent to Rs 13.60 crore for the quarter ended December 31, 2010, over the sam...
- Bliss GVS Ltd okays bonus issue
Bliss GVS Ltd, engaged in manufacturing health care and pharma products, today said it has approved the proposal to issue three bonus share...